{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T21:04:57Z","timestamp":1725311097143},"reference-count":23,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            In this study, the susceptibilities of 35 multidrug-resistant (MDR)\n            <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n            clinical isolates to second-line drugs, including kanamycin (KM), rifabutin (RBU), ofloxacin (OFX),\n            <jats:italic>p<\/jats:italic>\n            -aminosalicylic acid (PAS), capreomycin (CAP), clofazimine (CFM), and ethionamide (ETH), were investigated on blood agar according to CLSI recommendations. Compared with the results of the Bactec 460 TB system, agreement was 100, 100, 97, 100, 100, 100, and 86% for KM, RBU, OFX, PAS, CAP, CFM, and ETH, respectively. Compared with the results of the proportion method, agreement was 100, 100, 97, 100, 97, 100, and 77% for KM, RBU, OFX, PAS, CAP, CFM, and ETH, respectively.\n          <\/jats:p>","DOI":"10.1128\/jcm.00688-10","type":"journal-article","created":{"date-parts":[[2010,9,9]],"date-time":"2010-09-09T02:04:38Z","timestamp":1283997878000},"page":"4291-4293","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Testing Susceptibility of Multidrug-Resistant\n            <i>Mycobacterium tuberculosis<\/i>\n            to Second-Line Drugs by Use of Blood Agar"],"prefix":"10.1128","volume":"48","author":[{"given":"Dilek","family":"Satana","sequence":"first","affiliation":[{"name":"Istanbul University, Istanbul Medical School, Department of Microbiology and Clinical Microbiology, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Yilmaz","family":"Coban","sequence":"additional","affiliation":[{"name":"Ondokuz Mayis University, Medical School, Department of Microbiology and Clinical Microbiology, Samsun, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meltem","family":"Uzun","sequence":"additional","affiliation":[{"name":"Istanbul University, Istanbul Medical School, Department of Microbiology and Clinical Microbiology, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.4.1930-1931.2005"},{"key":"e_1_3_1_3_2","first-page":"450","volume":"10","year":"2006","unstructured":"Coban, A. Y., C. C. Cihan, K. Bilgin, M. Uzun, A. Akgunes, E. Cetinkaya, and B. Durupinar. 2006. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs. Int. J. Tuber. Lung Dis. 10 : 450-453.","journal-title":"Int. J. Tuber. Lung Dis."},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2008.20.3.388"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01104-08"},{"key":"e_1_3_1_6_2","first-page":"169","year":"1998","unstructured":"Della-Latta, P., and I. Weitzman. 1998. Mycobacteriology, p. 169-203. In H. D. Isenberg (ed.), Essential procedures for clinical microbiology. ASM Press, Washington, DC.","journal-title":"Essential procedures for clinical microbiology."},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.4.1710-1711.2003"},{"key":"e_1_3_1_8_2","first-page":"e83","volume":"28","year":"2007","unstructured":"Drancourt, M., and D. Raoult. 2007. Cost-effectiveness of blood agar for isolation of mycobacteria. PloS Negl. Trop. Dis. 28 : e83.","journal-title":"PloS Negl. Trop. Dis."},{"key":"e_1_3_1_9_2","unstructured":"Reference deleted."},{"key":"e_1_3_1_10_2","first-page":"127","year":"1996","unstructured":"Inderlied, C. B., and K. A. Nash. 1996. Antimycobacterial agents: in vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biologic fluids, p. 127-175. In W. Lorian (ed.), Antibiotic in laboratory medicine, 4th ed. Williams and Wilkins, Baltimore, MD.","journal-title":"Antibiotic in laboratory medicine"},{"key":"e_1_3_1_11_2","first-page":"1601","year":"1999","unstructured":"Inderlied, C. B., and M. Salfinger. 1999. Antimycobacterial agents and susceptibility tests, p. 1601-1623. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, DC.","journal-title":"Manual of clinical microbiology"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","unstructured":"Clinical microbiology procedures handbook 1:5.13.1-5.14.24. 1992","DOI":"10.1016\/0196-4399(92)90039-C"},{"key":"e_1_3_1_13_2","unstructured":"Kent P. T. and G. P. Kubica. 1985. Public health mycobacteriology. A guide for the level III laboratory division of laboratory training and consultation. CDC Press Atlanta GA."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh320"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00803-09"},{"key":"e_1_3_1_16_2","first-page":"208","volume":"56","year":"2009","unstructured":"Mathur, M. L., J. Gaur, R. Sharma, and A. Solanki. 2009. Rapid culture of Mycobacterium tuberculosis on blood agar in resource limited setting. Dan. Med. Bull. 56 : 208-210.","journal-title":"Dan. Med. Bull."},{"key":"e_1_3_1_17_2","unstructured":"Approved standard M24-A. 2003"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.10.3179-3186.1999"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.60.053107.103955"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.13.5.908-912.1981"},{"key":"e_1_3_1_21_2","unstructured":"Bactec 460 TB system. 1995"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2004.16.4.334"},{"key":"e_1_3_1_23_2","unstructured":"Reference deleted."},{"key":"e_1_3_1_24_2","first-page":"975","volume":"28","year":"2007","unstructured":"Yildiz, C., M. Ulger, G. Aslan, and G. Emekdas. 2007. Isoniazid susceptibilities of Mycobacterium tuberculosis on blood agar. Saudi Med. J. 28 : 975-977.","journal-title":"Saudi Med. J."}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00688-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00688-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T08:37:29Z","timestamp":1646469449000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.00688-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1128\/JCM.00688-10"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00688-10","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"2010-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-08-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}